statement: The topology of a peroxisomal enzyme is changed in response to fatty acid supplementation, triggering its appearance on lipid droplets.
Introduction
Fatty acids are a fundamental requirement for the biogenesis of membranes, and their oxidation generates efficiently energy in the form of ATP. It is therefore not surprising that almost all cells have the capacity to store fatty acid derivatives in specialized organelles now widely termed lipid droplets (LDs; Murphy, 2012; Walther and Farese Jr, 2012) . LDs are highly dynamic organelles, with their size and number dependent on nutrient supply and hormonal cues. Neutral lipids, such as triglycerides and cholesteryl esters, are stored in the hydrophobic core, which is surrounded by a phospholipid monolayer with embedded proteins. LD proteomics of mammalian cells revealed the presence of constitutively associated LD proteins (perilipins) and many enzymes of lipid metabolism (Bersuker et al., 2018; Brasaemle et al., 2004; Goodman, 2009; Liu et al., 2004) . Hydrophobic domains are somehow required for targeting of proteins to lipid droplets, but the mechanisms involved appear to be diverse and are not fully understood (Kory et al., 2016; Ohsaki et al., 2014; Thiele and Spandl, 2008) .
Fatty acyl-CoA reductases (Far) are peroxisomal membrane proteins that catalyze the formation of fatty alcohols from fatty acyl-CoA and NADPH (Cheng and Russell, 2004) , which in turn are utilized for ether lipid synthesis. In mammals, the Far family is represented by Far1 and Far2, which show a high overall homology of 58% (Cheng and Russell, 2004) . Far1 expression has been found in most of the tissues whereas the distribution of Far2 mRNA is more restricted (Cheng and Russell, 2004) . Patients with a homozygous knockout of the FAR1 gene suffer from severe epilepsy, cataract and profound growth and mental retardation (Buchert et al., 2014) , suggesting that Far2 cannot compensate for Far1 at the whole organism level. Most peroxisomal membrane proteins are synthesized on free ribosomes in the cytosol and are inserted into the peroxisomal membrane either by direct targeting (class I proteins) or via the ER (class II proteins) (Smith and Aitchison, 2013) .
Membrane protein topology describes the number and orientation of one or more hydrophobic domains relative to the membrane. The vast majority of membrane-associated proteins possesses only one stable configuration. However, there is a small subset of proteins that show changes in the orientation of one, multiple or all transmembrane helices upon membrane insertion, resulting in complex topological variants (von Heijne, 2006) . The phenomenon of multiple topologies of a single protein is very rare, and neither the evolutionary background nor the mechanisms of exhibiting multiple topological variants are understood satisfyingly. Here, we demonstrate that Far1 is also located on lipid droplets, and suggest that this is due to the presence of two different topological orientations.
Materials and Methods

Cell culture, transient and stable expression
Human osteosarcoma U-2 OS cells were cultured in McCoys 5A modified medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% FCS (Life Technologies, Carlsbad, CA, USA), 2 mM L-glutamine (GlutaMAX, Life Technologies, Carlsbad, CA, USA) and 1% penicillin/streptomycin (Life Technologies, Carlsbad, CA, USA). Cells were subcultured when reaching 80% confluence. Human immortalized SZ95 sebocytes (Zouboulis et al., 1999) were cultured in Sebomed ® basal medium (Merck, Kenilworth, NJ, USA) supplemented with 10% FCS, 1 mM CaCl2 and 5 ng/ml hEGF. Human A431 epidermoid carcinoma cells (ATCC CRL-1555) were grown in DMEM 4.5 g/l glucose (Life Technologies #41965) containing the same supplements as U-2 OS cells. All cell lines were routinely tested for mycoplasma contamination and authenticated.
For transient expression, cells were grown on coverslips to 80-90% confluence and transfected with FugeneHD (Promega, Madison, WI, USA). Briefly, the transfection mix for a 12 well plate with 0.8 ml medium included 40 µl of OptiMEM (Life Technologies, Carlsbad, CA, USA), 0.8 µg total DNA and 4 µl FugeneHD (Promega, Madison, WI, USA). For 6-well plates, the ratios were adjusted to 2 ml medium. After 4 h, the transfection mix was removed and cells were cultured overnight in antibiotic-free medium. Lipid droplet growth was induced by adding 600 µM oleate (from a 8.66 mM OA:BSA stock solution; molar ratio 6:1; oleic acid O1383 from Sigma, fatty acid free BSA A8806from Sigma, St. Louis, MO, USA). The OAmedium was present on the cells overnight, if not indicated otherwise.
For stable expression, the constructs were integrated into the genome by retroviral transduction as described elsewhere (Schuck et al., 2004) . Briefly, phoenix-gp cells were transfected with the indicated fusion protein cDNAs cloned into the retroviral pRIJ vector (Küch et al., 2014) or pRIJ-neo vector. Viral particles contained in the media supernatants were harvested and applied to the cells, followed by antibiotic selection of the transduced target cells (puromycin: 2 µg/ml, 48 h; neomycin: 2 mg/ml for 4 days). Cells were never allowed to reach densities above 90% during the selection process.
Plasmids
Full length Far1 cDNA was obtained from a cDNA library of SZ95 sebocytes (Zouboulis et al., 1999) and was cloned with PacI and KpnI into a modified version of pEGFP-N1 (Clontech) containing a FLAG epitope at the 3´-end of GFP (Far1-GFP-FLAG). Sequencing confirmed the cDNA to be 100% identical to the database entry (NM_032228.5).
For the N-terminally tagged version, the full length coding region of Far1 was amplified, cloned into mCherry-C1 (Clontech) and subsequently subcloned yielding FLAG-mCherry-Far1.
FLAG-mCherry-Far1 was the basis for all further cloned deletion mutants ( Fig. 4B ), double epitope tag variants ( Fig. 3 and Fig. 5 ) and the opsin tagged variants (Fig. 3) .
The opsin glycosylation tag (Bano-Polo et al., 2011; Favaloro et al., 2008; Nilsson and von Heijne, 1993) consisted of the amino acid sequence AASGSGPNFYVPFSNKTLEGPIL derived from the bovine sequence. The N-glycosylation motif NxT was changed to QKT for the opsin control construct. Both tags were preceded by amino acids 451-515 of Far1.
The N-terminus of ACSL3 (aa 1-135 of human ACSL3) fused to GFP/BFP was used as a lipid droplet marker protein . As an endoplasmic reticulum marker, a signal sequence (CD8)-GFP-KDEL cDNA sequence was transfected. Alternatively, the endoplasmic reticulum resident acyl-CoA-synthetase FATP4/ACSVL5 (Milger et al., 2006) was used. Fluorescent proteins containing a C-terminal SKL tag (GFP-SKL and BFP-SKL) were used as lumenal peroxisomal marker proteins. The full length cDNA of human pex11β fused to GFP or mCherry respectively, was used as a marker for peroxisomal membranes (Koch et al., 2010) . Details on the plasmid sequences, cloning strategies and primers are freely available upon request. All constructs created were sequenced for validation.
Antibodies
Immunofluorescence was performed with rabbit anti-CaBP1 (Fullekrug et al., 1994) , rabbit anti-FLAG (Sigma F7425, St. Louis, MO, USA; 1:1000 for IF) and mouse anti-HA (Santa Cruz SC-7392, Dallas, TX, USA; 1:200 for IF). As a lipid droplet marker, anti-TIP47 antibody (R&D Systems, Minneapolis, MN, USA, 1:600) was used. For western blotting, mouse anti-FLAG (Sigma F1804 St. Louis, MO, USA; 1:4000), rabbit anti-HA (Santa Cruz SC-805 Dallas, TX, USA; 1:1000) and mouse anti-actin (Sigma A5441 St. Louis, MO, USA; 1:40.000) were used. As markers for the ER, anti-calnexin (Thermo Fisher Scientific, Waltham, MA, USA, 1:200) was detected. Anti-ACSL3 (Abnova, Taipei, Taiwan, 1:3000) served as a marker for lipid droplets. Anti-pex19 antibody (Thermo Fisher Scientific, Waltham, MA, USA) was used in a 1:10.000 dilution for western blot. The Far1 antibody was raised against an Nterminal fragment (Novus Biologicals, Centennial, CO, USA; NBP1-89847) and was used at a 1:100 dilution for immunofluorescence and 1:2000 for western blot. Anti-pex13 (Millipore, Burlington, MA, USA; #ABC143) was used at a 1:5000 dilution for western blot.
Immunofluorescence and microscopy
U-2 OS cells were grown on 10 mm coverslips and fixed with 4% paraformaldehyde in PBS for 20 minutes. Cells that were not processed for immunofluorescence were mounted in mowiol-glycerol solution (MOWIOL 4-88; Calbiochem, San Diego, CA, USA).
For conventional immunofluorescence, the cells were permeabilized with 0.1% saponin and blocked with 0.5% gelatin and 0.5% BSA (SGB) for 10 min at room temperature. The cells were incubated with the first antibody diluted in SGB for 1h. The coverslip was subsequently washed three times with SG-buffer (0.1% saponin, 0.5% gelatin) and the secondary antibodies were diluted in SGB and applied for 60 min. After two washes with SG-buffer and two washes in PBS the cells were mounted as above.
Immunostaining of endogenous Far1 included a denaturation step with 6 M guanidine hydrochloride for 10 min before Far1 antibodies (1:100) were applied. Sequential staining was used for double immunofluorescence; permeabilized-blocked cells were stained for ACSL3 first, followed by an extra 20 min 4% PFA fixation step and finally by the denaturation protocol to allow Far1 immunostaining.
For immunofluorescence under selective permeabilization conditions, cells were fixed as described above and permeabilized with 10 µM digitonin for 10 min on ice. Permeabilization with 1% Triton-X 100 on ice solubilized all membranes, and served as a staining control.
Cells were subsequently blocked with 1% BSA for 1 h at room temperature and incubated with the first antibody diluted in 1% BSA for 1 h. Cells were then washed three times for five minutes with PBS and incubated with the secondary antibody diluted in PBS for 1 h at room temperature. After additional three washes for five minutes in PBS, the cells were embedded in MOWIOL. The intraluminal ER protein CaBP1 (Fullekrug et al., 1994) was used to verify the inaccessibility of extracytoplasmic epitopes after digitonin permeabilization.
Neutral lipids were stained with 2 µg/ml BODIPY 493/503 (Invitrogen D-3922, Waltham, MA, USA) or 1 µM monodansylpentane (MDH; Abgent, SM1000a, San Diego, CA, USA) diluted in PBS for 15 min at room temperature.
Raw images were acquired on an Olympus BX41 microscope, 60x oil immersion Plan S Apo NA 1.35, F-view II CCD camera, cell^D software. Gamma values reached from 1.5 (ER structures) over 1.3 (peroxisomes) to 1.0 (lipid droplets).
Lipid droplet localization scoring: The subcellular distribution of mCherry-FAR1 was assessed manually by distinguishing five categories, yielding a score from 0 to 1. Cells with mCherry-FAR1 being only localized to peroxisomes received a score of 0, whereas minimal but significant presence on lipid droplets qualified for a score of 0.25. A score of 0.5 was given if the localization of mCherry-FAR1 on peroxisomes and lipid droplets was close to be evenly distributed. When mCherry-FAR1 was dominantly located on lipid droplets but with a remaining peroxisomal localization, the cell was assigned a score of 0.75 whereas a score of 1 indicated the complete presence of FAR1 on lipid droplets without any remaining peroxisomal localization.
Pearson correlation coefficient analysis: The images were first deconvolved using the imageJ plugin "Diffraction PSF 3D" (Dougherty, 2005) together with a point spread function matching the technical settings of the Olympus BX41 microscope. Colocalization of the marker protein and the respective Far1 construct was assessed by the Coloc2 plugin of imageJ, using the Pearson correlation coefficient to quantify the colocalization in images (no thresholding was applied).
HA/FLAG epitope tagging quantification (Figs. 3A, 5E): The fluorescence intensities of 75 randomly chosen cells from three independent experiments were assessed by imageJ after thresholding (15,000-65,535 in 16bit images in Figure 3A , without thresholding in Figure 5E ).
The ratio of the HA derived fluorescence and FLAG derived fluorescence was calculated for each cell individually.
Correlative light electron microscopy (CLEM)
Cells were seeded at a low density in MatTek dishes (Ashland, MA, USA) having glass gridded coverslips with an alphanumeric pattern for relocating cells or cells clusters. After treatment, cells were fixed with 4% PFA and 0.2% glutaraldehyde in PBS for 30 min. After fixation, the cells were washed three times with 150 mM glycine and twice with PBS. Subsequently cells were imaged with a Nikon Ti Eclipse microscope equipped with an Ultraview VoX confocal spinning disc system (PerkinElmer, Waltham, MA, USA). First, cells were imaged at 20x magnification (20x objective, Plan Fluor, NA 0.75, oil), to record the positions of the cells of interest expressing fluorescent proteins. Then 60x magnification images (60x objective: Apo TIRF, NA 1.49, oil) were also acquired to improve the correlation with the electron microscopy (EM) data. Post-fixation of the cells was carried out with 2% osmium tetroxide (OsO4) in 50 mM Na-cacodylate buffer for 40 min on ice. Afterwards, the cells were washed three times with ddH2O and stained with 0.5% uranyl acetate (UA) in H2O for 30 min.
After three additional washes with ddH2O the cells were dehydrated in an increasing ethanol series at room temperature (40%, 50%, 60%, 70% and 80%) for five minutes each followed by 95% and 100% ethanol for 20 min each. The cells were then quickly immersed in 100% propylene oxide and embedded in an Araldite-Epon mixture (Araldite 502/Embed 812 kit, Electron Microscopy Sciences, Hatfield, PA, USA). The samples were incubated for 48 h at 60°C for polymerization of the resin. The MatTek dishes and the gridded coverslips were subsequently removed from the polymerized resin blocks and the embedded cell monolayers were sectioned using a Leica Ultracut UCT ultramicrotome (Leica Microsystems) and a diamond knife (Ultra 35 ° from Diatome). Finally the 70 nm sections were counter-stained with 2% UA in 70 % methanol and lead citrate in CO2-free H2O and visualized under a JEM-1400 (JEOL) TEM equipped with a TemCam-F416 digital camera system (TVIPS) operated at 120 kV. Correlations between the light microscopy images and the electron micrographs were calculated using the non-rigid transformation of the Icy ec-CLEM plugin (http://icy.bioimageanalysis.org/) (Paul-Gilloteaux et al., 2017) . CLEM as applied here has been described in detail recently (Romero-Brey, 2018) .
Subcellular fractionation
Lipid droplets were prepared by a sucrose step gradient (modified after (Thul et al., 2017) and ). Cells were grown to subconfluency in two 180 cm² plates and treated with or without 600 µM oleic acid overnight. The following steps were carried out at 4°C. Cells were washed three times with PBS, collected by scraping and pelleted. The pellet was resuspended in buffer A1 (50 mM Tris-HCl pH 7.4, 20 mM sucrose, 1 mM EDTA, 1 mM β-mercaptoethanol) and homogenized using 10 strikes with a G22 needle and additional 23 strikes with a G25 needle. The postnuclear supernatant (PNS) was obtained by centrifugation at 1,000xg for 10 min. The PNS was centrifuged at 100,000xg (TLA55 rotor) for 60 min to obtain a membrane pellet and the cytosolic supernatant including lipid droplets. To further separate the cytosol from lipid droplets, the supernatant was adjusted to 2.7 ml with buffer A1 and mixed with 2.7 ml of buffer A4 (50 mM Tris-HCl pH 7.4, 1.08 M Sucrose, 1 mM EDTA, 1 mM β-mercaptoethanol). Together, it formed the bottom layer of the sucrose gradient. This was carefully overlayed with 1.8 ml of buffer A3 (50 mM Tris pH 7.4, 270 mM Sucrose, 1 mM EDTA, 1 mM β-mercaptoethanol), buffer A2 (50 mM Tris pH 7.4, 135 mM Sucrose, 1 mM EDTA, 1 mM β-mercaptoethanol) and buffer A1. This step gradient was centrifuged for 105 min at 150,000xg in an SW41TI rotor. Eight 1.35 ml fractions were collected from top to bottom. Fractions 1-8 were precipitated with chloroform: methanol and resuspended in 40 µl sample buffer (2% SDS (w/v), 62.5 mM Tris pH 6.8, 10% (v/v) glycerol, 100 mM β-mercaptoethanol). The membrane pellet was directly dissolved in 320 µl sample buffer. 10 µl of each fraction were subjected to SDS-PAGE with subsequent western blot analysis. Densitometry values were normalized to 1.0 for each protein from all fractions, and the average relative ratio between Far1 and pex11ß in the LD fractions calculated as 2.7 (from three independent fractionations: 3.1, 2.2 and 2.6).
Ether lipid analysis
U-2 OS wildtype cells were seeded at 80.000 cells/well (12-well plate), and incubated for 18 h in either starvation medium (1 g/L glucose DMEM, 200 µM fatty acid free BSA), standard growth medium, or oleation medium (600 µM bound to BSA). [ 14 C]acetate (NEC084HSB; PerkinElmer) was added to a final concentration of 10 µM at 50 Ci/mol for 6 h. Lipids were extracted based on the Folch protocol as described in detail recently (Poppelreuther et al., 2018) . Vacuum dried lipids were resuspended in 3% sodium methoxide (Sigma-Aldrich, St.
Louis, MO, USA) in methanol, and incubated for 20 min at 50°C at 300rpm. The reaction was stopped by the addition of 13.5 µl glacial acetic acid and the samples placed on ice. Lipids were extracted as before, spotted on a TLC plate and developed in chloroform:methanol:glacial acetic acid (65:25:10 v/v) for 35 min. Incorporation of radioactivity was detected by phosphorimaging plates, scanned by the BAS-1500 system (Fuji, Tokyo, Japan) and quantified by imageJ.
Protease protection assay
Stably expressing FLAG-FAR1-HA.U-2 OS were seeded in 180 cm² plates and treated with 600 µM oleate bound to BSA for 24 h. The cells of each plate were scraped and resuspended in 600 µl homogenization buffer (50 mM Tris-HCl pH 7.4, 20 mM sucrose, 1 mM EDTA) and homogenized by passing the cells 20x through a G22 needle. Postnuclear supernatants (PNS) were obtained by centrifugation at 1,000xg for 10 min. Membranes were sedimented by centrifugation at 100,000xg in a TLA45 rotor. The supernatant containing lipid droplets and cytosolic proteins was carefully removed and the pellet was resuspended in 600 µl homogenization buffer. Digestion with 1 µg of proteinase K (New England Biolabs, Ipswich, MA, USA)/ 200 µl sample was for 30 min at 4°C. Triton X-100 (1%) was used to solubilize all membranes as a control. The reaction was terminated by the addition of 600 µl methanol and 140 µl chloroform. Proteins were recovered by sedimentation and solubilized in 2x sample buffer (4% SDS (w/v), 125 mM Tris-HCl pH 6.8, 20% glycerol, 200 mM β-mercaptoethanol) for SDS-PAGE.
Yeast strains and transformations
For evaluation of hsFar1 localization in yeast, the cDNA coding for FLAG-mCherry-Far1 was cloned into pYX142 (R&D Systems, Minneapolis, MN, USA) using PCR primers encoding XmaI and NheI restriction sites (s_BglII_XmaI_FLAG 5'-acgtagatctcccgggaccatggactacaaggacgacg-3' and a_NheI_XbaI_NotI_Far1Ct 5'-acgtgctagctctagagcggccgctcagtatctcatagtgctgg-3'). For the microscopy analysis, the lipid droplet marker Erg6 (Pu et al., 2011) and the peroxisomal marker Pxa1 (Shani et al., 1996) in the yeast strains BY4741 GFP-Pxa1 (his3∆1 leu2∆0 met15∆0 ura3∆0 hph∆n::URA3::SpNOP1pr-GFP-Pxa1) and BY4741 GFP-Erg6 (his3∆1 leu2∆0 met15∆0 ura3∆0 hph∆n: min, wells were washed twice with SD-riboflavin complete medium (for strains in glucose) or with double-distilled water (for strains in oleate) to remove non-adherent cells and to obtain a cell monolayer. The plates were then transferred to the ScanR inverted fluorescent microscope system (Olympus, Tokyo, Japan). Images of cells in the 384-well plates were recorded in the same liquid as the washing step at 24°C using a 60x air lens (NA 0.9) and with an ORCA-ER charge-coupled device camera (Hamamatsu, Hamamatsu, Japan). Images were acquired in two channels: GFP (excitation filter 490/20 nm, emission filter 535/50 nm) and mCherry (excitation filter 572/35 nm, emission filter 632/60 nm). All images were taken at a single focal plane.
Pex19-knockout cells
For generating the pex19 knockout cell lines, plasmid eSpCas9(1.1) Addgene # 71814 (Slaymaker et al., 2015) was modified to include a puromycin resistance gene. The guide for pex19 (Schrul and Kopito, 2016) was generated by annealing sense (5´-caccgtgtcggggccgaagcggac-3´) and antisense (5´-aaacgtccgcttcggccccgacac-3´) oligonucleotides and ligation into the backbone containing the Cas9 plasmid cut with BbsI. U-2 OS cells were transfected in 6 well plates; a Cas9 vector without a guide sequence served as control. 24 h post transfection the cells were trypsinized and treated with 2 µg/ml puromycin for 48 h. After an additional 24 h, cells were trypsinized and thirty cells were seeded into 60 cm² dishes.
Two weeks after transfection, single cell clones were transferred to a 24 well plate. Single cell clones were screened by eGFP-SKL transfection for the absence of peroxisomes and verified by western blotting.
ASNA1/TRC40-knockout pool
Knockout of ASNA1 was mediated by transfection of a plasmid containing SpCas9 ( (Ran et al., 2013) Addgene #62988) and a guide RNA targeting exon 3 of the TRC40-gene (sense 5´-caccgcctgacgagttcttcgagg-3´, antisense 5´-aaaccctcgaagaactcgtcaggc-3´). After puromycin selection (2 µg/ml) for 48 h the cells were grown for two weeks with cell densities above 30%. No single cell clones could be obtained. For the preparation of genomic DNA, 50,000 cells were resuspended in 17 µl ddH2O, 2 µl of 10x Taq-PCR-Buffer (QIAGEN, Hilden, Germany) and 800 U proteinase K (New England Biolabs, Ipswich, MA, USA). Incubation at 65°C for 60 min was followed by heat inactivation for 15 min at 95°C. The targeted genomic region was amplified by conventional PCR and sequenced. The knockout efficiency was estimated by the TIDE algorithm (Brinkman et al., 2014) , comparing the sequence chromatograms derived from the wildtype locus and the guide-targeted locus. The knockout was further confirmed by western blotting and estimated to reduce ASNA1 expression by > 95%.
Antibodies used were rabbit anti TRC40 (Proteintech 15450-1-AP), and rabbit anti tubulin (Proteintech 11224-1-AP). The antibody incubation was carried out in PBS-0.1% Tween-20 overnight at 4°C. Blots were imaged using an Odyssey Sa Infrared imaging system with IRDye LiCOR secondary antibodies.
Software
Guides for ASNA1 were designed with CRISPOR (http://crispor.tefor.net/). Genomic alterations were estimated with the TIDE algorithm (Brinkman et al., 2014) . Hydrophobicity scores were generated and evaluated by TMHMM 2.0 (http://www.cbs.dtu.dk/services/TMHMM/); (Krogh et al., 2001) . The helical wheel projection was generated by HeliQuest 
Results
The biochemistry of long chain fatty acids is at the heart of the complex lipid metabolic network. Here, we analyzed the localization and targeting of fatty acyl-CoA reductase 1 (Far1) primarily in human osteosarcoma U-2 OS cells to gain further insights into the topology and subcellular compartmentalization of fatty acid metabolism.
Localization of Far1 to peroxisomes and lipid droplets
Fatty acyl-CoA reductases are not widely studied, and there appeared to be no suitable antibodies for immunocytochemistry protocols available. Therefore, we cloned the cDNA of Far1 from the human sebaceous gland cell line SZ95 and designed a mCherry-Far1 fusion plasmid. Transient expression in U-2 OS cells showed numerous dot-like structures throughout the cytoplasm which overlapped with the peroxisomal membrane marker GFP-pex11β ( Fig.   1A ), consistent with earlier work (Honsho et al., 2013) .
Far1 localized to lipid droplets (LDs) after oleate (OA) supplementation, as indicated by the colocalization with the LD marker Plin-3/TIP47, and the segregation from pex11ß (Fig. 1A) .
This surprising finding was further confirmed by neutral lipid staining demonstrating an abundance of lipid droplets surrounded by mCherry-Far1 (Fig. 1A) . A LD localization score was devised to account for cell-to-cell variation, and demonstrated that an average cell would show a dominant LD localization of Far1 with remaining peroxisomes. The Pearson correlation coefficient between Far1 and pex11ß decreased from 0.70 to 0.31 after OA treatment, whereas the value for Far1 and the LD marker A3Nt-GFP increased from -0.07 to 0.40 respectively (Fig. 1B) . The presence of Far1 on lipid droplets was both time and OA concentration dependent (Suppl. Fig. S1A ). Regression of lipid droplets by starvation lead to the disappearance of LD associated Far1 even before the LDs were completely consumed (Suppl. Fig. S1B ), consistent with the situation for cells cultured at steady state which also harbor some lipid droplets (Fig. 1A) .
Palmitate or arachidonate supplementation also triggered the appearance of Far1 on LDs albeit with a lower efficiency (Suppl. Fig. S2 ). Lipid droplets were generally much smaller and less abundant compared to oleate, suggesting these fatty acids were not as efficiently taken up and converted to triglycerides.
The 65 C-terminal amino acids of Far1 were sufficient to allow targeting of a fluorescent reporter to lipid droplets in oleate treated U-2 OS cells (mCherry-Far1Ct; Fig. 1C) . The same Cterminal region is also necessary for the targeting of Far1 to peroxisomes (Honsho et al., 2013) .
To enable characterization at a higher resolution, we established U-2 OS cells stably expressing mCherry-Far1 together with the lipid droplet marker A3Nt-GFP by retroviral transduction. Analysis by correlative light electron microscopy (CLEM) showed that the fluorescent signal of both mCherry-Far1 and A3Nt-GFP corresponded to lipid droplets, which were identified by transmission electron microscopy (TEM) as large circular homogenously electron dense structures surrounded by a more electron dense line (Fig. 1D) . ER tubules were identified by EM but did not correspond to the circular fluorescence pattern of Far1 and A3Nt-GFP. Additionally, mCherry-positive structures were also associated with electron dense stratified organelles presumably corresponding to peroxisomes.
To enable the direct comparison of two peroxisomal membrane associated proteins by subcellular fractionation, epitope tagged variants of Far1 and pex11ß were stably co-expressed by retroviral transduction (3xFLAG-GFP-Far1.3xHA-mCherry-pex11β.U-2 OS cells). Lipid droplets were enriched by sedimenting most of the other cellular membranes for 1 h at 100,000xg. The supernatant was further subfractionated by sucrose density gradient centrifugation and analyzed by western blotting (Fig. 1E ). Far1 was enriched 2.7-fold over pex11ß in the LD fractions, even if it did not reach the levels of our lipid droplet marker protein (endogenous ACSL3).
Preliminary screening of several other cell lines for the expression of Far1 by western blotting suggested that A431 epidermoid carcinoma cells might be a suitable model system to investigate endogenous Far1. However, initial standard immunofluorescence protocols employing either chemical (PFA) or solvent (methanol at -20°C) fixation gave only background signal. It was only after including a guanidine hydrochloride antigen denaturation step (Peranen et al., 1993 ) that the available commercial antibody recognized endogenous Far1 in U-2 OS and A431 cells, overlapping with endogenous ACSL3 or surrounding the Bodipy neutral lipid stain after oleate treatment ( Fig. 2A) . Further confirmation of endogenous Far1 associating with lipid droplets was obtained by western blotting of subcellular fractions for both U-2 OS and A431 cells (Fig. 2B ).
Ether lipid synthesis as assessed by the quantification of radiolabeled ethanolamine plasmalogens was decreased in oleate treated U-2 OS cells, even though the expression of endogenous Far1 was increased more than twofold and the total amount of peroxisomes was not significantly changed (Suppl. Fig. S3 ).
Targeting of proteins to lipid droplets appears to be quite conserved across evolutionary distant model systems. Therefore, we tested if the LD localization of Far1 would be conserved in S. cerevisiae, even if yeast does not synthesize ether lipids itself. However, human Far1 localized neither to peroxisomes nor to lipid droplets when expressed in S. cerevisiae (Suppl. Fig. S4 ); see also Discussion.
Two different topologies of Far1
On peroxisomes, Far1 displays a classical type I membrane topology with most of the protein including the enzyme domain exposed to the cytosol, and a short luminal tail (Honsho et al., 2013) . This topology however is not found on lipid droplet associated proteins because the hydrophobic core does not allow penetration by charged amino acids (Kory et al., 2016) . In addition, lipid droplets are surrounded by a phospholipid monolayer which is too narrow to incorporate standard integral transmembrane bilayer domains.
To resolve this apparent conflict, we used double epitope tagging of Far1 (FLAG-Far1-HA) combined with selective permeabilization. Digitonin solubilizes the plasma membrane but not intracellular membranes like the ER or peroxisomes, allowing access of antibodies only to cytoplasmically oriented epitopes. Antibodies against the C-terminal HA epitope tag stained Far1 only when it was present on lipid droplets in oleate treated cells, or if the nondiscriminative detergent Tx-100 was used (Fig. 3A) . This suggested that the orientation of the C-terminus would be towards the cytosol on lipid droplets but extracytosolic/intralumenal on peroxisomes.
Protease protection of subcellular fractions form oleate treated U-2 OS cells was used as an independent method for verification. Sedimented membranes containing peroxisomes retained proteolytic fragments recognized by HA antibodies, suggesting that the C-terminus of Far1 is not accessible from the cytosolic side. Far1 recovered from the lipid droplet containing supernatant however was efficiently digested (Fig. 3B ).
Targeting of LD proteins starts either from the ER or from the cytosol (Kory et al., 2016) . To distinguish between these possibilities, we applied glycosylation tagging of Far1 with an opsin derived sequence (Bano-Polo et al., 2011; Favaloro et al., 2008; Nilsson and von Heijne, 1993) . Stably expressing cells were analyzed by western blotting and immunofluorescence ( Fig. 3C ). Partial glycosylation of Far1 constructs was observed only with intact N-glycosylation motifs, as compared to the opsin control sequence containing two point mutations. Remarkably, glycosylation was not only present in oleate treated cells but also if cells underwent starvation to remove lipid droplets. This suggested that in our model system, the ER would also be a part of the trafficking itinerary towards peroxisomes. Both opsin constructs were partially found on lipid droplets (Fig. 3C) , likely corresponding to the nonglycosylated variants because N-glycoproteins are neither expected to be found on LDs nor has there been any report of this, to the best of our knowledge.
The C-terminus of Far1 contains two distinct membrane association domains
In silico transmembrane domain prediction by TMHMM (Krogh et al., 2001) suggested two Cterminal hydrophobic domains (HDs), of which the first one (HD1: aa 466-484) reached the threshold for a bona fide transmembrane domain, whereas the second hydrophobic domain (HD2: aa 492-510) did not (Fig. 4A ). Starting with mCherry-Far1Ct (Fig. 1C) , either HD1 or HD2 were deleted (overview of constructs: Fig. 4B ) and analyzed for their localization. Both mCherry-HD1 and mCherry-HD2 localized to the ER under steady state conditions (Figs. 4C,   4D ). Oleate treatment did not change the localization of mCherry-HD1 ( Fig. 4C ) but mCherry-HD2 overlapped strikingly with the lipid droplet marker A3Nt-GFP (Fig. 4D) . Pearson correlation coefficient analysis confirmed that mCherry-HD1 did not overlap with LDs whereas mCherry-HD2 showed high values for LD colocalization but reduced ER overlap (Fig. 4E) .
Neither of the constructs localized to peroxisomes, likely because the putative binding site for the peroxisomal sorting chaperone pex19 (Honsho et al., 2013; Van Ael and Fransen, 2006) was compromised.
Both constructs were double epitope tagged and retrovirally transduced into U-2 OS cells, followed by selective permeabilization analysis as above. The HD1 construct behaved like a type I integral membrane protein of the ER, with the C-terminal HA epitope oriented into the lumen and only accessible after using TX-100 for complete permeabilization of all subcellular membranes (Fig. 5A) . Remarkably, the HD2 construct was stained efficiently when using digitonin, suggesting that both the N-and the C-terminus were facing the cytosol (Fig 5B) .
The HD1 and HD2 mCherry constructs still contained adjacent amino acids from the Far1 sequence. To further analyze the two HDs, only the hydrophobic domains themselves were used to replace the HD of the A3Nt-GFP lipid droplet marker (Figs. 5C,D) . While the hydrophobic domain of ACSL3 allows both the N-and C-terminus to be oriented towards the cytosol at the ER and on LDs , there is no consensus yet whether this is due to the formation of an amphipathic helix or a hairpin motif (Kory et al., 2016; Pataki et al., 2018) . Regardless, the corresponding A3Nt-HD2-GFP construct behaved virtually indis-tinguishable from A3Nt-GFP, overlapping extensively with lipid droplets after oleate incubation (Fig. 5D ), and with Sec61ß at the ER under steady state conditions (Fig. S5 ). A3Nt-HD1-GFP localized to mitochondria, which was consistent with in silico predictions for a mitochondrial targeting peptide (http://www.cbs.dtu.dk/services/TargetP/; not shown).
Targeting of Far1 to lipid droplets is independent of pex19 or ASNA1
The sorting of Far1 to peroxisomes depends on the cytosolic trafficking chaperone pex19 (Honsho et al., 2013) . Recently, pex19 has also been implicated in the targeting of UBXD8 towards lipid droplets via the ER (Schrul and Kopito, 2016) . To test a possible involvement of pex19 in the targeting of Far1 to lipid droplets, pex19 was inactivated in U-2 OS cells by CRISPR/Cas9 mediated indel formation (Fig. 6A ). As expected, peroxisomes were absent as verified here by the cytosolic location of the peroxisomal SKL reporter protein (Fig. 6B) .
However, the localization of Far1 on lipid droplets was not impaired (Fig 6B) . Re-expression of pex19 restored peroxisomal sorting of BFP-SKL (Suppl. Fig. S6 ).
ASNA1/TRC40 targets C-terminal anchored membrane proteins to the ER (Borgese and Fasana, 2011; Guna et al., 2018; Rabu et al., 2009 ). Since the membrane association domains of Far1 are also located at the C-terminus, we considered a role for ASNA1 in the targeting of Far1 (to the ER; further trafficking towards LDs would be mediated either by the HD2 domain or additional factors). For unknown reasons, single cell derived clonal lines could not be obtained after targeting of ASNA1 by CRISPR/Cas9. Instead, cells were selected for the transient presence of Cas9 and propagated as a pool of cells with an estimated overall knockdown efficiency of >95% as assessed by western blotting (Fig. 6C ) and genome sequencing (Suppl. Fig. S7 ). The localization of Far1 on lipid droplets was not changed, however (Fig. 6D ). The knockdown of ASNA1 was also applied in the pex19-KO background, but again did not change the LD localization of Far1 (Fig. 6E ).
Discussion
Localization of Far1 to lipid droplets
We demonstrated the presence of exogenous and endogenous Far1 on lipid droplets in U-2 OS cells by several independent methods, and showed that the C-terminal 65 amino acids are sufficient for this unusual localization of a peroxisomal membrane protein (Figs. 1, 2) . LD association of endogenous Far1 was also demonstrated for a second model system (A431 cells; Fig. 2 ). Additionally, Far1 was also observed on LDs in oleate treated epithelial COS-7 cells by fluorescence microscopy, and the closely related Far2 protein was equally localized
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to LDs (not shown). Consistent with our results, proximity labeling based proteomics suggested that Far1 is the most abundant peroxisomal protein on lipid droplets of U-2 OS cells (Bersuker et al., 2018) . Endogenous Far1 was also detected in lipid droplet fractions prepared from oleate treated HeLa cells by mass spectrometry (B.S., manuscript in preparation) .
Following the localization of Far1 over time (Suppl. Fig. S1A ) suggested that Far1 arrives late on lipid droplets, unlike ACSL3 which is already present 2 min after oleate addition (Kassan et al., 2013; Poppelreuther et al., 2012) . Our data are also more consistent with a gradual appearance of Far1 on LDs, and would therefore be different from GPAT4 which appears to transit spontaneously within a short time frame from the ER to LDs .
Upon starvation, Far1 also disappears earlier than ACSL3 from LDs (Suppl. Fig. S1B ). It is currently unclear if this is due to turnover/degradation of Far1, or if it is "crowded out" early (Kory et al., 2015) , because the LD affinity may be lower than for other more tightly associated LD proteins. The subcellular fractionation data are also consistent with our interpretation that Far1 associates less avidly with lipid droplets than ACSL3. Remarkably, we made the incidental observation that Far1 did not move to lipid droplets in oleate treated HuH-7 human hepatoma cells but remained on peroxisomes (not shown). This suggests that these particular cells may lack one of the putative required factors for movement of Far1 to lipid droplets, which will be addressed in future studies.
Close proximity between peroxisomes and LDs has been observed previously in different model organisms, sometimes enhanced by the remarkable flexibility of peroxisomal protrusions and tubules (Binns et al., 2006; Gao and Goodman, 2015; Hayashi et al., 2001; Schrader, 2001; Schuldiner and Bohnert, 2017) . Peroxisomal extensions were also suggested to transfer the A. thaliana lipase SDP1 to lipid droplets during early seedling growth (Thazar-Poulot et al., 2015) . In our hands, tubular peroxisomes were apparent during high overexpression of Far1 in COS-7 cells (not shown) but were only very rarely observed in U-2 OS cells.
Heterologous expression of human Far1 in the yeast S. cerevisiae indicated that the localization to LDs is not universally conserved. Far1 was localized to the ER in glucose medium, and to the vacuole when oleate was the main energy and carbon source (Suppl. Fig. S4 ), but neither to peroxisomes nor to lipid droplets. Since sorting of mammalian Far1 to peroxisomes is pex19 dependent (Honsho et al., 2013) , this suggests that the yeast pex19 homologue does not recognize the sorting motif contained within human Far1. On a side note, yeast does not have an endogenous fatty acyl-CoA reductase (Far) activity, and does not synthesize ether lipids.
Targeting of proteins to lipid droplets may be broadly categorized by their respective original localizations, i.e. the ER or the cytosol (Kory et al., 2016; Ohsaki et al., 2014; Thiele and Spandl, 2008) . ER derived membrane proteins appear to lack intralumenal domains so that they may be readily accommodated in the monolayer LD membrane; they also revert to the ER if lipid droplets are consumed during starvation (Zehmer et al., 2009 ). Far1 does not fit well into this class of LD proteins because it is neither an ER protein originally nor is it located at the ER under starvation. It also displays an intralumenal domain while on peroxisomes (Honsho et al., 2013) and is partially located at the ER (as evidenced by N-glycosylation; Fig.   3 ).
Integral transmembrane domains and the corresponding topology are usually well predicted by the TMHMM algorithm (Krogh et al., 2001) . However, when it comes to lipid droplet associated proteins we found it rarely to be consistent with experimental data (not shown), presumably because of the obvious difficulty of squeezing a "standard" TMD into the phospholipid monolayer. Hairpin topologies and amphipathic helices, which are typical for LD proteins pose a formidable future challenge to bioinformatics.
The targeting mechanism of Far1
The role of the ER for peroxisomal targeting and biogenesis is discussed controversially (Buentzel et al., 2015; Erdmann, 2016; Lodhi and Semenkovich, 2014; Mayerhofer, 2016; Smith and Aitchison, 2013) . N-glycosylation of the Far1 reporter proteins (Fig. 3) indicated that at least about 50% of Far1 associated transiently with the ER in our model system, presumably before further transport towards the peroxisome was accomplished.
Pex19 is a cytosolic chaperone implicated in the targeting of peroxisomal membrane proteins (Jones et al., 2004) , and it is also required for the sorting of Far1 to peroxisomes (Honsho et al., 2013) . This traditional view has been extended by recent findings that pex19 is also involved in transporting the hairpin protein UBXD8 to the endoplasmic reticulum, from where it moves onwards to lipid droplets (Schrul and Kopito, 2016) . However, while our pex19-KO cells replicated the expected phenotype (loss of peroxisomes), the localization of Far1 on lipid droplets or at the ER was not impaired (Fig. 6A,B ).
Far1 is also a tail-anchored membrane protein (Honsho et al., 2013) , which is at least transiently exposed to the N-glycosylation machinery at the ER (Fig. 3C) . Several chaperone assisted targeting pathways have been described (Borgese and Fasana, 2011; Guna et al., 2018) . The probably most prominent sorting mechanism involves TRC40/Get3p/ASNA1, which was also required for targeting peroxisomal proteins to the ER (van der Zand et al., 2006) . However, depletion of TRC40 did not affect Far1 LD localization to any significant extent (Figs. 6C,D) . In hindsight, our most likely explanation would be that the targeting of tail anchored proteins involves a rather redundant machinery (Rabu et al., 2009) . We also tried a double pex19/ASNA1-KO approach, but again Far1 was still found on LDs (Fig. 6E ). Knocking out even more chaperones would be expected to show severe side effects (the translocon component sec61ß is also a tail anchored protein), and was not tried here. We con-clude that Far1 targeting to the ER and lipid droplets is robustly supported by the cellular machinery of mammalian cells and is unlikely to be dependent on one single factor.
Far1 is a novel dual topology membrane protein
We propose that Far1 may be integrated into the ER membrane in two different ways (Fig.   7 ). The first topology features an integral transmembrane domain (first hydrophobic domain; HD1) and an amphipathic helix-like second domain (HD2), which associates primarily with the lumenal leaflet of the ER membrane. This appears also to be the only form competent for export/integration to peroxisomes and satisfyingly explains our glycosylation, selective permeabilization and protease sensitivity data.
The alternative second topology might be driven by a strong preference of the HD2 domain for the cytosolic leaflet of the ER under conditions of increased triglyceride synthesis. Molecular dynamics simulations indicate that the properties of the surrounding phospholipid monolayer are significantly affected by the underlying neutral lipids (Bacle et al., 2017; Prevost et al., 2018) , leading to packaging defects which would be even more pronounced during rapid LD growth. Amphipathic helices containing bulky hydrophobic amino acids would show synergistic binding (Copic et al., 2018; Prevost et al., 2018) ; the HD2 domain contains several of these amino acids, and wheel projections suggest a sidedness typical for amphipathic helices ( Fig. 7) . Consistent with this, HD2 appeared as efficient as the native ACSL3 hydrophobic domain in terms of LD targeting (Fig. 5D ). ACSL3 is considered a bona fide lipid droplet protein (Fujimoto et al., 2004; Poppelreuther et al., 2012; Walther et al., 2017) and is already present on emerging LDs (Kassan et al., 2013) . If HD2 associates first with the membrane, the short loop of intermittent amino acids would no longer allow an integral transmembrane orientation for HD1. This topology has the short C-terminal region exposed to the cytosol and is therefore in line with our permeabilization and protease sensitivity data for LD localized Far1.
Summarizing speculatively, the targeting of Far1 may be determined by a kinetic competition between an insertion machinery recognizing HD1, and the affinity of HD2 for the cytoplasmic surface of the ER. Under conditions of increased triglyceride synthesis, binding of HD2 could simply be faster/stronger than the recognition of HD1. The binding affinity of HD2 for the phospholipid monolayer would then pull the Far1 molecule onto growing lipid droplets. The incorporation of HD1 into the outer leaflet of the ER membrane might constitute an opposing force, delaying the transfer of Far1 to LDs.
Alternative scenarios may involve direct trafficking from peroxisomes to LDs as exemplified by the A. thaliana lipase SDP1 (Thazar-Poulot et al., 2015) or a retrograde transport from peroxisomes to the ER (Passreiter, 1998; Titorenko and Rachubinski, 1998) . However this would involve moving the lumenal short hydrophilic segments of the Far1 C-terminus across the hydrophobic phospholipid layer which is considered energetically highly unfavorable.
Dual topology is a rare phenomenon, and most cases described so far involve multipass transmembrane domain proteins (>3 TMDs; Lambert and Prange, 2001; Rapp et al., 2006; Stockbridge et al., 2014; Wurie et al., 2011) . Generally, the orientation of membrane proteins is considered to be determined during their cotranslational insertion into the membrane, but post-assembly topology switching does occur (Bogdanov et al., 2014) . We applied the term "dual topology" to mean that one amino acid sequence occurs in two different topological orientations with respect to a phospholipid membrane (Granseth, 2010) . However, dual topology has also been more narrowly defined as proteins which "insert into the membrane in two opposite orientations with an approximate 1:1 stoichiometry" (von Heijne, 2006 ). This would not encompass Far1, because the alternative topology of Far1 is restricted to the Cterminus and does not change the cytosolic orientation of the enzyme domain. Moreover, the stoichiometry of the two Far1 topologies is not fixed but appears dependent on the extent of triglyceride synthesis.
The topologies of Far1 appear to be strongly correlated to the subcellular localization. Far1 converts fatty acyl-CoA to fatty alcohols; on peroxisomes these are further metabolized by lumenal enzymes and are finally incorporated into ether lipids. Far1 on lipid droplets may therefore reduce the production of ether lipids from exogenously supplied fatty acids, which would be consistent with our ethanolamine plasmalogen quantification (Suppl. Fig. S3 ). This speculative scenario is reminiscent of the protein storage "depot" function of lipid droplets (Cermelli et al., 2006) . However, clarification clearly requires future studies e.g. employing localization-fixed Far1 versions targeted exclusively to either the ER, LDs or peroxisomes.
The metabolic fate of LD synthesized fatty alcohols is currently unclear and beyond the scope of this study. They could enter a fatty alcohol cycle, which would be involved in cellular lipid homeostasis (Rizzo, 2014) , balancing ether and non-ether lipid levels. In line with this, the vast majority of externally added hexadecanol was converted to palmitate rather than to ether lipids in cultured fibroblasts (Rizzo et al., 1987) . Other metabolic routes are also conceivable, as many enzymes of lipid metabolism are found on LDs (Goodman, 2009 ).
Finally, tantalizing recent data suggest that lipid droplet and peroxisome biogenesis may occur at the same ER subdomains marked by mammalian MCTP2/yeast Pex30 and seipin (Joshi et al., 2018; Wang et al., 2018) . This spatial proximity may well be the mechanistic basis for the alternative sorting pathways of Far1, and may also be instrumental in allowing dual topologies upon insertion into the membrane. (A) U-2 OS and A431 were cultured in standard growth medium (-OA) or supplemented with oleate (+OA). Indirect immunofluorescence required a pre-denaturation step to allow specific binding of Far1 antibodies, followed by Cy3-conjugated secondary antibodies (red). Neutral lipids were stained with Bodipy 493/503 (green), and endogenous ACSL3 served as a LD marker protein (green). Bar, 10 µm. 4B. Digitonin permeabilizes the plasma membrane but no intracellular membranes, allowing access of antibodies only to cytoplasmatically oriented epitopes. Indirect immunofluorescence with anti-FLAG (red) and anti-HA (green) antibodies indicated that the C-terminus of Far1 is oriented towards the inside of the peroxisomes (first row) at standard growth conditions (-OA). After oleate supplementation (+OA), HA antibodies efficiently stained lipid droplets (third row), suggesting that both N-and C-terminus are exposed to the cytosol. Note that remaining peroxisomal Far1 was not stained by the HA antibodies (third row). Triton-X-100 solubilizes all membranes indiscriminately and was used as a staining control (second and fourth row). Bar 10µm.
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Fluorescence intensities were quantified for 75 randomly chosen cells from n=3 independent experiments. The ratios of HA/FLAG were calculated for each cell individually, and are presented as the mean ± s.d.
(B) Protease protection assay. Stably expressing FLAG-Far1-HA.U-2 OS were incubated overnight with oleate, homogenized and subjected to a 100,000xg spin for 1 h, resulting in a membrane pellet (PELLET) and the supernatant (SPNT) containing lipid droplets. Aliquots were incubated with proteinase K (PK) and with/without the detergent Triton X-100 (TX). Protease resistant fragments containing the HA epitope were readily observed in the pellet fraction containing peroxisomes (Pex13), but were significantly decreased in the lipid droplet fraction (49.2% protection vs. 25.7%). Far1 antibody staining indicated that the enzyme domain is partially resistant to digestion, consistent with earlier studies (Honsho et al., 2013 ). 
